Diaceutics PLC PDMR Shareholding/Share Incentive Plan (2327B)
May 31 2023 - 11:13AM
UK Regulatory
TIDMDXRX
RNS Number : 2327B
Diaceutics PLC
31 May 2023
31 May 2023
Diaceutics PLC
("Diaceutics" or "the Company")
PDMR Shareholding/Share Incentive Plan
Diaceutics PLC , ( AIM: DXRX), a leading technology and
solutions provider to the pharmaceutical industry, has been
notified that on 30 May 2023, Global Shares Trustees (UK) Limited
and Zedra Trust Company (Guernsey) Limited, the trustees of the
Global Diaceutics plc 2020 Employee Benefit Trust , have purchased
ordinary shares ("Shares") on behalf of Susanne Munksted, Jordan
Clark, Julie Browne and Nick Roberts (PDMRs), in respect of their
purchase of Shares pursuant to the Company's UK and Global Share
Incentive Plan ("the SIP Schemes") for employees . These purchases
will be made each month until further notice.
In accordance with the SIP Schemes, the Company has matched
these purchases with a matched share award over an equivalent
number of Shares purchased by the employee, in the proportion of
1:1.
Enquiries:
Diaceutics PLC
Nick Roberts, Chief Financial Officer Via Alma PR
Stifel Nicolaus Europe Limited (Nomad & Broker) Tel: +44 (0)20 7710
7600
Ben Maddison
Nick Harland
Nick Adams
Alma PR Tel: +44(0)20 3405
0205
Caroline Forde diaceutics@almapr.co.uk
Kieran Breheny
Matthew Young
Kinvara Verdon
About Diaceutics
At Diaceutics we believe that every patient should get the
opportunity to receive the right test and the right therapy to
positively impact their disease outcome. We provide the world's
leading pharmaceutical and life science companies with solutions
and technology for the commercialisation of their precision
medicines, enabled by the proprietary DXRX platform.
DXRX is the world's first diagnostic commercialisation platform
for precision medicine, utilising a global network of affiliate
laboratories to deliver multiple pipelines of real-world healthcare
data insights, advisory services and innovative platform enabled
solutions.
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
-----------------------------------------------------------------------------------
a. Name Susanne Munksted
--------------------------- ------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Precision Medicine Officer and PDMR
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
--------------------------- ------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a. Name Diaceutics PLC
--------------------------- ------------------------------------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Global Share
Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ----- ------------ ---------------- ---------------
0.82 p 183
-------------------------------------- ------------ ---------------- ---------------
Conditional share award:
----- ------------------------------ ---------------
Price(s) Volume(s)
----- ------------ ---------------- ---------------
Nil 183
-------------------------------------- ------------ ---------------- ---------------
e. Date of the transaction Share purchase and Conditional share award:
30 May 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase: AIM Market of the London
Stock Exchange
Conditional share award: Off-Market
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
-----------------------------------------------------------------------------------
a. Name Jordan Clark
--------------------------- ------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Commercial Officer and PDMR
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
--------------------------- ------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a. Name Diaceutics PLC
--------------------------- ------------------------------------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ----- ------------ ---------------- ---------------
0.82 p 183
-------------------------------------- ------------ ---------------- ---------------
Matched share award:
----- ------------------------------ ---------------
Price(s) Volume(s)
----- ------------ ---------------- ---------------
0.82 p 183
-------------------------------------- ------------ ---------------- ---------------
e. Date of the transaction Share purchase and Matched Share award:
30 May 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase and Matched Share Award:
AIM Market of the London Stock Exchange
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
-----------------------------------------------------------------------------------
a. Name Julie Browne
--------------------------- ------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Operations Officer and PDMR
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
--------------------------- ------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a. Name Diaceutics PLC
--------------------------- ------------------------------------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ----- ------------ ---------------- ---------------
0.82 p 183
-------------------------------------- ------------ ---------------- ---------------
Matched share award:
----- ------------------------------ ---------------
Price(s) Volume(s)
----- ------------ ---------------- ---------------
0.82 p 183
-------------------------------------- ------------ ---------------- ---------------
e. Date of the transaction Share purchase and Matched Share award:
30 May 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase and Matched Share Award:
AIM Market of the London Stock Exchange
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
-----------------------------------------------------------------------------------
a. Name Nick Roberts
--------------------------- ------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Finance Officer and PDMR
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
--------------------------- ------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a. Name Diaceutics PLC
--------------------------- ------------------------------------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ----- ------------ ---------------- ---------------
0.82 p 183
-------------------------------------- ------------ ---------------- ---------------
Matched share award:
----- ------------------------------ ---------------
Price(s) Volume(s)
----- ------------ ---------------- ---------------
0.82 p 183
-------------------------------------- ------------ ---------------- ---------------
e. Date of the transaction Share purchase and Matched Share award:
30 May 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase and Matched Share Award:
AIM Market of the London Stock Exchange
--------------------------- ------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHNKDBDABKDDPN
(END) Dow Jones Newswires
May 31, 2023 12:13 ET (16:13 GMT)
Diaceutics (LSE:DXRX)
Historical Stock Chart
From Apr 2024 to May 2024
Diaceutics (LSE:DXRX)
Historical Stock Chart
From May 2023 to May 2024
